New FDA Program for Mail Back Envelopes for Opioids – Good News or Bad News?
On Monday, the FDA announced a change to the REMS for opioids to include a requirement “to make prepaid mail‑back envelopes available to outpatient pharmacies and other dispensers as an additional opioid analgesic disposal option for patients.” As part of the new, revised REMS requirement, “all manufacturers of opioid analgesics used in outpatient settings are […]
